Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-27
2007-02-27
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S452000
Reexamination Certificate
active
10570566
ABSTRACT:
A process for the synthesis of perindopril of formula (I):and its pharmaceutically acceptable salts.
REFERENCES:
patent: 49658 (1982-04-01), None
patent: 1319668 (2003-06-01), None
patent: 1321471 (2003-06-01), None
patent: 1371659 (2003-12-01), None
M.A. Huffman, et al., “Improved stereoselectivity in the heterogeneous catalytic synthesis of enalapril obtained through multidimensional screening” Tetrahedron Letters, vol. 40 No. 5 pp. 831-834, Jan. 29, 1999.
T.J. Blacklock, et al., “Synthesis of semisynthetic dipeptides using N-carboxxanhydrides andchiral induction of raney nickel. A method practical for large scale” Journal of Organic Chemistry, vol. 53 No. 4, pp. 836-844, 1988.
International Search Report for PCT/FR2004/002196, Feb. 3, 2005.
European Search Report for EP 03292132, Nov. 18, 2003.
Dubuffet Thierry
Lecouve Jean-Pierre
Barker Michael P.
Hueschen and Sage
Les Laboratoires Servier
LandOfFree
Metod for the synthesis of perindopril and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metod for the synthesis of perindopril and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metod for the synthesis of perindopril and the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870695